Case Control Study
Copyright ©The Author(s) 2016.
World J Hepatol. Feb 18, 2016; 8(5): 291-300
Published online Feb 18, 2016. doi: 10.4254/wjh.v8.i5.291
Table 1 Clinical features of patients with active hepatitis C virus infection (active hepatitis C virus group) and of those in whom hepatitis C virus infection was eradicated (eradication group) n (%)
Discrete traitsActive HCV group (n = 55)Eradication group (n = 55)P value
Sex0.254
Male22 (40)28 (51)
Female33 (60)27 (49)
HCV genotype0.003
1b48 (87)36 (65)
27 (13)19 (35)
Quantitative traitsMean ± SDMean ± SD
Age (yr)66.9 ± 11.264.3 ± 12.10.200
BMI (kg/m2)22.5 ± 3.222.8 ± 3.40.631
AST (IU/L)53.1 ± 27.524.0 ± 7.2< 0.001
ALT (IU/L)49.9 ± 37.120.0 ± 11.7< 0.001
Total bilirubin (mg/dL)0.8 ± 0.30.7 ± 0.30.242
γ-GTP (IU/L)50.4 ± 6427.1 ± 200.011
Albumin (g/dL)3.9 ± 0.44.4 ± 0.3< 0.001
Hb (g/dL)13.4 ± 1.714.2 ± 1.50.010
Platelet (104/μL)15.0 ± 6.320.0 ± 17.80.050
FBG (mg/dL)108 ± 32107 ± 160.740
HbA1c (%)5.4 ± 0.66.1 ± 0.50.030
Lipid profiles
Total cholesterol (mg/dL)173.6 ± 31200.5 ± 37.8< 0.001
Triglyceride (mg/dL)107.5 ± 52.0103 ± 53.10.712
LDL cholesterol (mg/dL)92.1 ± 25.7117 ± 29.9< 0.001
HDL cholesterol (mg/dL)59.9 ± 17.464.9 ± 19.00.159
CETP level (μg/mL)2.84 ± 1.002.40 ± 0.690.008